These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38706353)

  • 1. Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication.
    Iyengar ARS; Khandave PY; Bzdrenga J; Nachon F; Brazzolotto X; Pande AH
    Protein Pept Lett; 2024; 31(5):345-355. PubMed ID: 38706353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Human Paraoxonase 1 the Saviour Against the Persistent Threat of Organophosphorus Nerve Agents?
    Iyengar ARS; Pande AH
    Protein Pept Lett; 2019; 26(7):471-478. PubMed ID: 30942142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human butyrylcholinesterase efficacy against nerve agent exposure.
    Reed BA; Sabourin CL; Lenz DE
    J Biochem Mol Toxicol; 2017 May; 31(5):. PubMed ID: 28225154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.
    Iyengar AR; Pande AH
    Protein J; 2016 Dec; 35(6):424-439. PubMed ID: 27830420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
    Curtin BF; Seetharam KI; Dhoieam P; Gordon RK; Doctor BP; Nambiar MP
    J Cell Biochem; 2008 Apr; 103(5):1524-35. PubMed ID: 17879943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic bioscavengers in nerve agent poisoning: A promising approach?
    Worek F; Thiermann H; Wille T
    Toxicol Lett; 2016 Feb; 244():143-148. PubMed ID: 26200600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties.
    Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH
    Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical aspects of pharmacological prophylaxis against nerve agent poisoning.
    Bajgar J; Fusek J; Kassa J; Kuca K; Jun D
    Curr Med Chem; 2009; 16(23):2977-86. PubMed ID: 19689278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication.
    Cerasoli DM; Armstrong SJ; Reeves TE; Hodgins SM; Kasten SA; Lee-Stubbs RB; Cadieux CL; Otto TC; Capacio BR; Lenz DE
    Biochem Pharmacol; 2020 Jan; 171():113670. PubMed ID: 31628910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.
    Gupta RD; Goldsmith M; Ashani Y; Simo Y; Mullokandov G; Bar H; Ben-David M; Leader H; Margalit R; Silman I; Sussman JL; Tawfik DS
    Nat Chem Biol; 2011 Feb; 7(2):120-5. PubMed ID: 21217689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of antidotes: problems and strategies.
    Szinicz L; Worek F; Thiermann H; Kehe K; Eckert S; Eyer P
    Toxicology; 2007 Apr; 233(1-3):23-30. PubMed ID: 16949190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic prophylaxis against nerve agent poisoning.
    Layish I; Krivoy A; Rotman E; Finkelstein A; Tashma Z; Yehezkelli Y
    Isr Med Assoc J; 2005 Mar; 7(3):182-7. PubMed ID: 15792266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of oximes in the treatment of nerve agent poisoning in civilian casualties.
    Marrs TC; Rice P; Vale JA
    Toxicol Rev; 2006; 25(4):297-323. PubMed ID: 17288500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in mice.
    Betapudi V; Goswami R; Silayeva L; Doctor DM; Chilukuri N
    Sci Transl Med; 2020 Jan; 12(527):. PubMed ID: 31969483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two possibilities how to increase the efficacy of antidotal treatment of nerve agent poisonings.
    Kassa J; Musilek K; Karasova JZ; Kuca K; Bajgar J
    Mini Rev Med Chem; 2012 Jan; 12(1):24-34. PubMed ID: 22360668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning.
    Dobariya P; Adhya P; Vaidya B; Khandave PY; Sharma SS; Pande AH
    Enzyme Microb Technol; 2023 Apr; 165():110209. PubMed ID: 36764031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosporus insecticide and nerve agent poisonings.
    Sogorb MA; Vilanova E; Carrera V
    Toxicol Lett; 2004 Jun; 151(1):219-33. PubMed ID: 15177657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.